Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

MLA

Nicholas T Funderburg, et al. “Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.” Clinical Infectious Diseases, Apr. 2023. EBSCOhost, https://doi.org/10.1093/cid/ciad199.

APA

Nicholas T Funderburg, Carey L Shive, Zhengyi Chen, Curtis Tatsuoka, Emily R Bowman, Chris T Longenecker, Grace A McComsey, Brian M Clagett, Dominic Dorazio, Michael L Freeman, Scott F Sieg, Daniela Moisi, Donald D Anthony, Jeffrey M Jacobson, Sharon L Stein, Leonard H Calabrese, Alan Landay, Charles Flexner, Keith W Crawford, … Michael M Lederman. (2023). Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad199

Chicago

Nicholas T Funderburg, Carey L Shive, Zhengyi Chen, Curtis Tatsuoka, Emily R Bowman, Chris T Longenecker, Grace A McComsey, et al. 2023. “Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.” Clinical Infectious Diseases, April. doi:10.1093/cid/ciad199.